Veeva Systems Inc.

DB:VEE Stock Report

Market Cap: €36.3b

Veeva Systems Valuation

Is VEE undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of VEE when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
€199.39
Fair Value
12.3% overvalued intrinsic discount
29
Number of Analysts

Below Fair Value: VEE (€223.9) is trading above our estimate of fair value (€199.39)

Significantly Below Fair Value: VEE is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for VEE?

Key metric: As VEE is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for VEE. This is calculated by dividing VEE's market cap by their current earnings.
What is VEE's PE Ratio?
PE Ratio56.8x
EarningsUS$665.91m
Market CapUS$37.80b

Price to Earnings Ratio vs Peers

How does VEE's PE Ratio compare to its peers?

The above table shows the PE ratio for VEE vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average36x
NXU Nexus
44.3x16.9%€1.2b
COP CompuGroup Medical SE KGaA
48x30.1%€1.2b
SHL Siemens Healthineers
31.7x14.2%€63.0b
FME Fresenius Medical Care
19.9x16.8%€13.1b
VEE Veeva Systems
56.8x13.4%€37.8b

Price-To-Earnings vs Peers: VEE is expensive based on its Price-To-Earnings Ratio (56.8x) compared to the peer average (36x).

Price to Earnings Ratio vs Industry

How does VEE's PE Ratio compare vs other companies in the European Healthcare Services Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
VEE 56.8xIndustry Avg. 34.2xNo. of Companies3PE020406080100+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: VEE is expensive based on its Price-To-Earnings Ratio (56.8x) compared to the Global Healthcare Services industry average (34.2x).

Price to Earnings Ratio vs Fair Ratio

What is VEE's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

VEE PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio56.8x
Fair PE Ratio45.9x

Price-To-Earnings vs Fair Ratio: VEE is expensive based on its Price-To-Earnings Ratio (56.8x) compared to the estimated Fair Price-To-Earnings Ratio (45.9x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst VEE forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€223.90
€255.47
+14.1%
11.4%€308.70€188.12n/a29
Feb ’26€230.90
€255.47
+10.6%
11.4%€308.70€188.12n/a29
Jan ’26€203.00
€259.35
+27.8%
9.8%€308.90€188.23n/a30
Dec ’25€212.70
€234.70
+10.3%
11.4%€270.04€163.35n/a28
Nov ’25€191.20
€216.92
+13.4%
10.7%€264.41€159.94n/a27
Oct ’25€187.50
€209.69
+11.8%
10.0%€252.37€155.37n/a27
Sep ’25€199.00
€209.08
+5.1%
10.1%€254.25€156.53n/a27
Aug ’25€176.90
€204.07
+15.4%
11.0%€247.81€158.78n/a27
Jul ’25€169.80
€206.98
+21.9%
11.6%€251.37€161.06n/a26
Jun ’25€161.00
€209.63
+30.2%
11.9%€248.89€159.47n/a25
May ’25€188.55
€227.66
+20.7%
8.0%€254.21€188.30n/a27
Apr ’25€214.50
€220.58
+2.8%
8.1%€247.13€183.06n/a28
Mar ’25€200.70
€214.55
+6.9%
11.0%€249.16€147.65n/a28
Feb ’25€190.25
€196.15
+3.1%
11.4%€245.35€147.02€230.9026
Jan ’25€174.40
€191.82
+10.0%
11.0%€241.80€144.90€203.0027
Dec ’24€159.15
€196.89
+23.7%
11.5%€243.05€145.65€212.7027
Nov ’24€181.25
€215.10
+18.7%
9.2%€260.21€171.26€191.2027
Oct ’24€195.10
€210.73
+8.0%
9.2%€257.51€169.49€187.5025
Sep ’24€200.20
€206.65
+3.2%
9.0%€255.28€168.02€199.0026
Aug ’24€184.80
€194.29
+5.1%
11.2%€249.45€154.21€176.9027
Jul ’24€178.80
€194.64
+8.9%
11.1%€252.48€156.08€169.8026
Jun ’24€173.95
€194.96
+12.1%
11.7%€255.59€158.00€161.0026
May ’24€158.20
€189.67
+19.9%
11.1%€249.56€154.28€188.5525
Apr ’24€166.58
€192.94
+15.8%
11.1%€253.52€156.72€214.5025
Mar ’24€155.48
€194.28
+25.0%
10.1%€248.54€159.44€200.7026
Feb ’24€155.92
€194.03
+24.4%
10.2%€245.55€157.52€190.2527
Analyst Price Target
Consensus Narrative from 29 Analysts
€254.66
Fair Value
12.1% undervalued intrinsic discount
29
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/19 05:37
End of Day Share Price 2025/02/19 00:00
Earnings2024/10/31
Annual Earnings2024/01/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Veeva Systems Inc. is covered by 49 analysts. 31 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Joseph VruwinkBaird
Ishan MajumdarBaptista Research
Saket KaliaBarclays